Lauren P Silvernail bought stock once, on May 18, 2026

Lauren P. Silvernail is a corporate finance executive and board director who has served on the board of Harrow, Inc. (Nasdaq: HROW) since January 2024, where she is chair of the Audit Committee and a member of the Compensation Committee and the Nominating and Corporate Governance Committee ( Harrow appointed her to the board alongside Adrienne Graves, PhD, noting her experience as a financial and strategic advisor to boards and management teams and her track record of raising more than $1.3 billion in financing and completing numerous transactions for emerging growth companies (

Before joining Harrow’s board, Silvernail was chief financial officer and executive vice president of corporate development at Evolus, Inc. from 2018 to 2022, where she led financing efforts and helped build the infrastructure for the U.S. commercial launch of the company’s first approved product ( She also served as chief financial officer and vice president of corporate development at ISTA Pharmaceuticals from 2003 to 2012, a commercial ophthalmology company later acquired by Bausch and Lomb (

Written by Perplexity from public sources.